Pacer Advisors, Inc. Geron Corp Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$3.1 - $5.09 $17,732 - $29,114	-5,720 Reduced 50.97%	5,503 $23,000
Q1 2024 May 10, 2024	BUY	$1.75 - $3.44 $19,640 - $38,607	11,223 New	11,223 $37,000
Q2 2021 Jul 21, 2021	SELL	$1.25 - $1.83 $22,642 - $33,148	-18,114 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$1.52 - $2.1 $4,918 - $6,795	3,236 Added 21.75%	18,114 $29,000
Q4 2020 Jan 20, 2021	BUY	$1.55 - $2.05 $23,060 - $30,499	14,878 New	14,878 $24,000
Q4 2018 Feb 13, 2019	SELL	$0.98 - $1.85 $47,100 - $88,914	-48,062 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.76 - $6.38 $84,589 - $306,635	48,062 New	48,062 $85,000
Q1 2018 May 14, 2018	SELL	$1.81 - $5.98 $5,746 - $18,986	-3,175 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.8 - $2.32 $5,715 - $7,365	3,175	3,175 $6,000

275

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.54B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.